nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethambutol—Myocarditis—Epirubicin—bone cancer	0.0398	0.0398	CcSEcCtD
Ethambutol—Myocarditis—Doxorubicin—bone cancer	0.0368	0.0368	CcSEcCtD
Ethambutol—Blindness—Cisplatin—bone cancer	0.0342	0.0342	CcSEcCtD
Ethambutol—Optic neuritis—Cisplatin—bone cancer	0.0308	0.0308	CcSEcCtD
Ethambutol—Pericarditis—Methotrexate—bone cancer	0.024	0.024	CcSEcCtD
Ethambutol—Pericarditis—Epirubicin—bone cancer	0.0225	0.0225	CcSEcCtD
Ethambutol—Lung infiltration—Methotrexate—bone cancer	0.0222	0.0222	CcSEcCtD
Ethambutol—Pericarditis—Doxorubicin—bone cancer	0.0208	0.0208	CcSEcCtD
Ethambutol—Body temperature increased—Carboplatin—bone cancer	0.0182	0.0182	CcSEcCtD
Ethambutol—Blindness—Epirubicin—bone cancer	0.0176	0.0176	CcSEcCtD
Ethambutol—Blindness—Doxorubicin—bone cancer	0.0162	0.0162	CcSEcCtD
Ethambutol—Optic neuritis—Epirubicin—bone cancer	0.0158	0.0158	CcSEcCtD
Ethambutol—Optic neuritis—Doxorubicin—bone cancer	0.0146	0.0146	CcSEcCtD
Ethambutol—Anaphylactoid reaction—Cisplatin—bone cancer	0.0142	0.0142	CcSEcCtD
Ethambutol—Neuritis—Epirubicin—bone cancer	0.013	0.013	CcSEcCtD
Ethambutol—Scotoma—Epirubicin—bone cancer	0.0128	0.0128	CcSEcCtD
Ethambutol—Neuritis—Doxorubicin—bone cancer	0.012	0.012	CcSEcCtD
Ethambutol—Scotoma—Doxorubicin—bone cancer	0.0118	0.0118	CcSEcCtD
Ethambutol—Abdominal discomfort—Cisplatin—bone cancer	0.0114	0.0114	CcSEcCtD
Ethambutol—Neuropathy peripheral—Cisplatin—bone cancer	0.0104	0.0104	CcSEcCtD
Ethambutol—Visual impairment—Cisplatin—bone cancer	0.00916	0.00916	CcSEcCtD
Ethambutol—Lymphadenopathy—Methotrexate—bone cancer	0.00884	0.00884	CcSEcCtD
Ethambutol—Lymphadenopathy—Epirubicin—bone cancer	0.00827	0.00827	CcSEcCtD
Ethambutol—Hepatic function abnormal—Epirubicin—bone cancer	0.00807	0.00807	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Methotrexate—bone cancer	0.00799	0.00799	CcSEcCtD
Ethambutol—Vision blurred—Cisplatin—bone cancer	0.0078	0.0078	CcSEcCtD
Ethambutol—Anaphylactoid reaction—Methotrexate—bone cancer	0.00779	0.00779	CcSEcCtD
Ethambutol—Ill-defined disorder—Cisplatin—bone cancer	0.00768	0.00768	CcSEcCtD
Ethambutol—Lymphadenopathy—Doxorubicin—bone cancer	0.00765	0.00765	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Epirubicin—bone cancer	0.00748	0.00748	CcSEcCtD
Ethambutol—Hepatic function abnormal—Doxorubicin—bone cancer	0.00747	0.00747	CcSEcCtD
Ethambutol—Malaise—Cisplatin—bone cancer	0.00746	0.00746	CcSEcCtD
Ethambutol—Leukopenia—Cisplatin—bone cancer	0.00741	0.00741	CcSEcCtD
Ethambutol—Anaphylactoid reaction—Epirubicin—bone cancer	0.00729	0.00729	CcSEcCtD
Ethambutol—Liver function test abnormal—Methotrexate—bone cancer	0.00696	0.00696	CcSEcCtD
Ethambutol—Discomfort—Cisplatin—bone cancer	0.00696	0.00696	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00692	0.00692	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00679	0.00679	CcSEcCtD
Ethambutol—Anaphylactic shock—Cisplatin—bone cancer	0.00675	0.00675	CcSEcCtD
Ethambutol—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00675	0.00675	CcSEcCtD
Ethambutol—Thrombocytopenia—Cisplatin—bone cancer	0.00661	0.00661	CcSEcCtD
Ethambutol—Liver function test abnormal—Epirubicin—bone cancer	0.00651	0.00651	CcSEcCtD
Ethambutol—Eosinophilia—Methotrexate—bone cancer	0.00645	0.00645	CcSEcCtD
Ethambutol—Anorexia—Cisplatin—bone cancer	0.00644	0.00644	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00635	0.00635	CcSEcCtD
Ethambutol—Abdominal discomfort—Methotrexate—bone cancer	0.00625	0.00625	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00615	0.00615	CcSEcCtD
Ethambutol—Neutropenia—Methotrexate—bone cancer	0.00609	0.00609	CcSEcCtD
Ethambutol—Paraesthesia—Cisplatin—bone cancer	0.00606	0.00606	CcSEcCtD
Ethambutol—Eosinophilia—Epirubicin—bone cancer	0.00604	0.00604	CcSEcCtD
Ethambutol—Liver function test abnormal—Doxorubicin—bone cancer	0.00603	0.00603	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00588	0.00588	CcSEcCtD
Ethambutol—Decreased appetite—Cisplatin—bone cancer	0.00587	0.00587	CcSEcCtD
Ethambutol—Pneumonia—Methotrexate—bone cancer	0.00584	0.00584	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00576	0.00576	CcSEcCtD
Ethambutol—Neutropenia—Epirubicin—bone cancer	0.0057	0.0057	CcSEcCtD
Ethambutol—Eosinophilia—Doxorubicin—bone cancer	0.00559	0.00559	CcSEcCtD
Ethambutol—Feeling abnormal—Cisplatin—bone cancer	0.00557	0.00557	CcSEcCtD
Ethambutol—Pneumonia—Epirubicin—bone cancer	0.00547	0.00547	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00539	0.00539	CcSEcCtD
Ethambutol—Body temperature increased—Cisplatin—bone cancer	0.00534	0.00534	CcSEcCtD
Ethambutol—Neuropathy peripheral—Epirubicin—bone cancer	0.00533	0.00533	CcSEcCtD
Ethambutol—Neutropenia—Doxorubicin—bone cancer	0.00528	0.00528	CcSEcCtD
Ethambutol—Hepatitis—Methotrexate—bone cancer	0.00522	0.00522	CcSEcCtD
Ethambutol—Pneumonia—Doxorubicin—bone cancer	0.00506	0.00506	CcSEcCtD
Ethambutol—Visual impairment—Methotrexate—bone cancer	0.00503	0.00503	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00499	0.00499	CcSEcCtD
Ethambutol—Hypersensitivity—Cisplatin—bone cancer	0.00498	0.00498	CcSEcCtD
Ethambutol—Erythema multiforme—Methotrexate—bone cancer	0.00493	0.00493	CcSEcCtD
Ethambutol—Neuropathy peripheral—Doxorubicin—bone cancer	0.00493	0.00493	CcSEcCtD
Ethambutol—Hepatitis—Epirubicin—bone cancer	0.00488	0.00488	CcSEcCtD
Ethambutol—Hypoaesthesia—Epirubicin—bone cancer	0.00486	0.00486	CcSEcCtD
Ethambutol—Visual impairment—Epirubicin—bone cancer	0.0047	0.0047	CcSEcCtD
Ethambutol—Erythema multiforme—Epirubicin—bone cancer	0.00462	0.00462	CcSEcCtD
Ethambutol—Hepatitis—Doxorubicin—bone cancer	0.00452	0.00452	CcSEcCtD
Ethambutol—Hypoaesthesia—Doxorubicin—bone cancer	0.00449	0.00449	CcSEcCtD
Ethambutol—Visual impairment—Doxorubicin—bone cancer	0.00435	0.00435	CcSEcCtD
Ethambutol—Vomiting—Cisplatin—bone cancer	0.00429	0.00429	CcSEcCtD
Ethambutol—Vision blurred—Methotrexate—bone cancer	0.00428	0.00428	CcSEcCtD
Ethambutol—Erythema multiforme—Doxorubicin—bone cancer	0.00427	0.00427	CcSEcCtD
Ethambutol—Rash—Cisplatin—bone cancer	0.00426	0.00426	CcSEcCtD
Ethambutol—Dermatitis—Cisplatin—bone cancer	0.00425	0.00425	CcSEcCtD
Ethambutol—Ill-defined disorder—Methotrexate—bone cancer	0.00421	0.00421	CcSEcCtD
Ethambutol—Malaise—Methotrexate—bone cancer	0.00409	0.00409	CcSEcCtD
Ethambutol—Leukopenia—Methotrexate—bone cancer	0.00406	0.00406	CcSEcCtD
Ethambutol—Nausea—Cisplatin—bone cancer	0.00401	0.00401	CcSEcCtD
Ethambutol—Vision blurred—Epirubicin—bone cancer	0.004	0.004	CcSEcCtD
Ethambutol—Ill-defined disorder—Epirubicin—bone cancer	0.00394	0.00394	CcSEcCtD
Ethambutol—Arthralgia—Methotrexate—bone cancer	0.00387	0.00387	CcSEcCtD
Ethambutol—Malaise—Epirubicin—bone cancer	0.00383	0.00383	CcSEcCtD
Ethambutol—Discomfort—Methotrexate—bone cancer	0.00382	0.00382	CcSEcCtD
Ethambutol—Leukopenia—Epirubicin—bone cancer	0.0038	0.0038	CcSEcCtD
Ethambutol—Confusional state—Methotrexate—bone cancer	0.00374	0.00374	CcSEcCtD
Ethambutol—Anaphylactic shock—Methotrexate—bone cancer	0.00371	0.00371	CcSEcCtD
Ethambutol—Vision blurred—Doxorubicin—bone cancer	0.00371	0.00371	CcSEcCtD
Ethambutol—Ill-defined disorder—Doxorubicin—bone cancer	0.00365	0.00365	CcSEcCtD
Ethambutol—Thrombocytopenia—Methotrexate—bone cancer	0.00363	0.00363	CcSEcCtD
Ethambutol—Arthralgia—Epirubicin—bone cancer	0.00362	0.00362	CcSEcCtD
Ethambutol—Discomfort—Epirubicin—bone cancer	0.00357	0.00357	CcSEcCtD
Ethambutol—Malaise—Doxorubicin—bone cancer	0.00355	0.00355	CcSEcCtD
Ethambutol—Anorexia—Methotrexate—bone cancer	0.00353	0.00353	CcSEcCtD
Ethambutol—Leukopenia—Doxorubicin—bone cancer	0.00352	0.00352	CcSEcCtD
Ethambutol—Confusional state—Epirubicin—bone cancer	0.0035	0.0035	CcSEcCtD
Ethambutol—Anaphylactic shock—Epirubicin—bone cancer	0.00347	0.00347	CcSEcCtD
Ethambutol—Thrombocytopenia—Epirubicin—bone cancer	0.0034	0.0034	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00338	0.00338	CcSEcCtD
Ethambutol—Arthralgia—Doxorubicin—bone cancer	0.00335	0.00335	CcSEcCtD
Ethambutol—Paraesthesia—Methotrexate—bone cancer	0.00333	0.00333	CcSEcCtD
Ethambutol—Discomfort—Doxorubicin—bone cancer	0.00331	0.00331	CcSEcCtD
Ethambutol—Anorexia—Epirubicin—bone cancer	0.00331	0.00331	CcSEcCtD
Ethambutol—Confusional state—Doxorubicin—bone cancer	0.00324	0.00324	CcSEcCtD
Ethambutol—Decreased appetite—Methotrexate—bone cancer	0.00322	0.00322	CcSEcCtD
Ethambutol—Anaphylactic shock—Doxorubicin—bone cancer	0.00321	0.00321	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00316	0.00316	CcSEcCtD
Ethambutol—Thrombocytopenia—Doxorubicin—bone cancer	0.00314	0.00314	CcSEcCtD
Ethambutol—Paraesthesia—Epirubicin—bone cancer	0.00311	0.00311	CcSEcCtD
Ethambutol—Anorexia—Doxorubicin—bone cancer	0.00306	0.00306	CcSEcCtD
Ethambutol—Feeling abnormal—Methotrexate—bone cancer	0.00305	0.00305	CcSEcCtD
Ethambutol—Gastrointestinal pain—Methotrexate—bone cancer	0.00303	0.00303	CcSEcCtD
Ethambutol—Decreased appetite—Epirubicin—bone cancer	0.00301	0.00301	CcSEcCtD
Ethambutol—Abdominal pain—Methotrexate—bone cancer	0.00293	0.00293	CcSEcCtD
Ethambutol—Body temperature increased—Methotrexate—bone cancer	0.00293	0.00293	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00292	0.00292	CcSEcCtD
Ethambutol—Paraesthesia—Doxorubicin—bone cancer	0.00288	0.00288	CcSEcCtD
Ethambutol—Feeling abnormal—Epirubicin—bone cancer	0.00286	0.00286	CcSEcCtD
Ethambutol—Gastrointestinal pain—Epirubicin—bone cancer	0.00284	0.00284	CcSEcCtD
Ethambutol—Decreased appetite—Doxorubicin—bone cancer	0.00279	0.00279	CcSEcCtD
Ethambutol—Abdominal pain—Epirubicin—bone cancer	0.00274	0.00274	CcSEcCtD
Ethambutol—Body temperature increased—Epirubicin—bone cancer	0.00274	0.00274	CcSEcCtD
Ethambutol—Hypersensitivity—Methotrexate—bone cancer	0.00273	0.00273	CcSEcCtD
Ethambutol—Feeling abnormal—Doxorubicin—bone cancer	0.00264	0.00264	CcSEcCtD
Ethambutol—Gastrointestinal pain—Doxorubicin—bone cancer	0.00262	0.00262	CcSEcCtD
Ethambutol—Pruritus—Methotrexate—bone cancer	0.00262	0.00262	CcSEcCtD
Ethambutol—Hypersensitivity—Epirubicin—bone cancer	0.00256	0.00256	CcSEcCtD
Ethambutol—Body temperature increased—Doxorubicin—bone cancer	0.00254	0.00254	CcSEcCtD
Ethambutol—Abdominal pain—Doxorubicin—bone cancer	0.00254	0.00254	CcSEcCtD
Ethambutol—Pruritus—Epirubicin—bone cancer	0.00245	0.00245	CcSEcCtD
Ethambutol—Dizziness—Methotrexate—bone cancer	0.00245	0.00245	CcSEcCtD
Ethambutol—Hypersensitivity—Doxorubicin—bone cancer	0.00236	0.00236	CcSEcCtD
Ethambutol—Vomiting—Methotrexate—bone cancer	0.00236	0.00236	CcSEcCtD
Ethambutol—Rash—Methotrexate—bone cancer	0.00234	0.00234	CcSEcCtD
Ethambutol—Dermatitis—Methotrexate—bone cancer	0.00233	0.00233	CcSEcCtD
Ethambutol—Headache—Methotrexate—bone cancer	0.00232	0.00232	CcSEcCtD
Ethambutol—Dizziness—Epirubicin—bone cancer	0.00229	0.00229	CcSEcCtD
Ethambutol—Pruritus—Doxorubicin—bone cancer	0.00227	0.00227	CcSEcCtD
Ethambutol—Vomiting—Epirubicin—bone cancer	0.00221	0.00221	CcSEcCtD
Ethambutol—Nausea—Methotrexate—bone cancer	0.0022	0.0022	CcSEcCtD
Ethambutol—Rash—Epirubicin—bone cancer	0.00219	0.00219	CcSEcCtD
Ethambutol—Dermatitis—Epirubicin—bone cancer	0.00218	0.00218	CcSEcCtD
Ethambutol—Headache—Epirubicin—bone cancer	0.00217	0.00217	CcSEcCtD
Ethambutol—Dizziness—Doxorubicin—bone cancer	0.00212	0.00212	CcSEcCtD
Ethambutol—Nausea—Epirubicin—bone cancer	0.00206	0.00206	CcSEcCtD
Ethambutol—Vomiting—Doxorubicin—bone cancer	0.00204	0.00204	CcSEcCtD
Ethambutol—Rash—Doxorubicin—bone cancer	0.00202	0.00202	CcSEcCtD
Ethambutol—Dermatitis—Doxorubicin—bone cancer	0.00202	0.00202	CcSEcCtD
Ethambutol—Headache—Doxorubicin—bone cancer	0.00201	0.00201	CcSEcCtD
Ethambutol—Nausea—Doxorubicin—bone cancer	0.00191	0.00191	CcSEcCtD
